CircPVT1 Promotes Lung Metastasis and Tumor Progression in Renal Cell Carcinoma by Encoding the cP104aa Peptide and Targeting EIF4A3
Advanced Science · 2025
DOI: 10.1002/advs.202501211 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Houliang Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Affiliated Zhongda Hospital of Southeast University, Nanjing, 210009, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, RNA, Circular, Kidney Neoplasms, Lung Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Research Personnel Cultivation Programme of Zhongda Hospital Southeast University.
Abstract (Originalsprache)
Circular RNA (circRNA) plays a pivotal role in the pathogenesis of renal cell carcinoma (RCC). CircRNAs regulate gene expression via RNA‐binding proteins (RBPs) and also exert biological effects through peptide encoding. CircPVT1 has been previously identified as an oncogenic circRNA. This study identified that circPVT1 encodes a 104‐amino acid peptide, termed cP104aa. Functional assays showed that circPVT1 and the cP104aa peptide enhance RCC cell proliferation, invasion, migration, and lung metastasis both in vitro and in vivo. Mechanistically, the cP104aa peptide interacts with HNRNPK, leading to reduced c‐MYC ubiquitination and increased c‐MYC expression. Additionally, circPVT1 directly associates with EIF4A3, facilitating the expression of the target gene c‐MYC. Furthermore, axitinib is shown to target the degradation of the cP104aa peptide. These findings reveal a novel mechanism by which circPVT1 contributes to RCC, highlighting the potential of the cP104aa peptide as a therapeutic target. Axitinib may serve as an effective therapeutic agent for patients with advanced RCC exhibiting high cP104aa expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Affiliated Zhongda Hospital of Southeast University, Nanjing, 210009, China.
- Department of Urology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, China.
- Department of Urology, Nanjing Lishui District People's Hospital, Zhongda Hospital Lishui Branch, Southeast University, Nanjing, 211200, China.
- Surgical Research Center, Institute of Urology, Southeast University Medical School, Nanjing, 210009, China.
ORCID-Profile: Weipu Mao
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- Research Personnel Cultivation Programme of Zhongda Hospital Southeast University
- Jiangsu Provincial Medical Key Discipline
- SEU Innovation Capability Enhancement Plan for Doctoral Students
Zitieren
APA
Zhang, H., Tao, T., Ji, J., Zhao, T., Sun, S., Zhang, L., Wu, J., Chen, M., Chen, S., Xu, B., & Mao, W. (2025). CircPVT1 Promotes Lung Metastasis and Tumor Progression in Renal Cell Carcinoma by Encoding the cP104aa Peptide and Targeting EIF4A3. Advanced Science. https://doi.org/10.1002/advs.202501211
Vancouver
Zhang H, Tao T, Ji J, Zhao T, Sun S, Zhang L, et al. CircPVT1 Promotes Lung Metastasis and Tumor Progression in Renal Cell Carcinoma by Encoding the cP104aa Peptide and Targeting EIF4A3. Advanced Science. 2025. doi:10.1002/advs.202501211
BibTeX
@article{Zhang2025,
author = {Zhang, Houliang and Tao, Tao and Ji, Jie and Zhao, Tonglei and Sun, Si and Zhang, Lijie and Wu, Jianping and Chen, Ming and Chen, Shuqiu and Xu, Bin and Mao, Weipu},
title = {CircPVT1 Promotes Lung Metastasis and Tumor Progression in Renal Cell Carcinoma by Encoding the cP104aa Peptide and Targeting EIF4A3},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202501211}
}
EUVIMED